Gemcitabine and vascular toxicity

Lung Cancer. 2002 Aug;37(2):229. doi: 10.1016/s0169-5002(02)00152-6.
No abstract available

Publication types

  • Comment
  • Letter

MeSH terms

  • Antimetabolites, Antineoplastic / adverse effects*
  • Antimetabolites, Antineoplastic / therapeutic use
  • Deoxycytidine / adverse effects*
  • Deoxycytidine / analogs & derivatives*
  • Deoxycytidine / therapeutic use
  • Gemcitabine
  • Hepatic Veno-Occlusive Disease / chemically induced*
  • Humans
  • Lung Neoplasms / drug therapy*
  • Lung Neoplasms / pathology
  • Treatment Outcome
  • Vasculitis / chemically induced*

Substances

  • Antimetabolites, Antineoplastic
  • Deoxycytidine
  • Gemcitabine